These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 29716922)
1. MEIS1 and MEIS2 Expression and Prostate Cancer Progression: A Role For HOXB13 Binding Partners in Metastatic Disease. Bhanvadia RR; VanOpstall C; Brechka H; Barashi NS; Gillard M; McAuley EM; Vasquez JM; Paner G; Chan WC; Andrade J; De Marzo AM; Han M; Szmulewitz RZ; Vander Griend DJ Clin Cancer Res; 2018 Aug; 24(15):3668-3680. PubMed ID: 29716922 [No Abstract] [Full Text] [Related]
2. HOXB13 interaction with MEIS1 modifies proliferation and gene expression in prostate cancer. Johng D; Torga G; Ewing CM; Jin K; Norris JD; McDonnell DP; Isaacs WB Prostate; 2019 Mar; 79(4):414-424. PubMed ID: 30560549 [TBL] [Abstract][Full Text] [Related]
3. Deregulation of a Hox protein regulatory network spanning prostate cancer initiation and progression. Chen JL; Li J; Kiriluk KJ; Rosen AM; Paner GP; Antic T; Lussier YA; Vander Griend DJ Clin Cancer Res; 2012 Aug; 18(16):4291-302. PubMed ID: 22723371 [TBL] [Abstract][Full Text] [Related]
4. MEIS-mediated suppression of human prostate cancer growth and metastasis through HOXB13-dependent regulation of proteoglycans. VanOpstall C; Perike S; Brechka H; Gillard M; Lamperis S; Zhu B; Brown R; Bhanvadia R; Vander Griend DJ Elife; 2020 Jun; 9():. PubMed ID: 32553107 [TBL] [Abstract][Full Text] [Related]
5. Expression of ISL1 and its partners in prostate cancer progression and neuroendocrine differentiation. Alshalalfa M; Abou-Ouf H; Davicioni E; Karnes RJ; Alhajj R; Bismar TA J Cancer Res Clin Oncol; 2021 Aug; 147(8):2223-2231. PubMed ID: 33864110 [TBL] [Abstract][Full Text] [Related]
6. MEIS1 down-regulation by MYC mediates prostate cancer development through elevated HOXB13 expression and AR activity. Whitlock NC; Trostel SY; Wilkinson S; Terrigino NT; Hennigan ST; Lake R; Carrabba NV; Atway R; Walton ED; Gryder BE; Capaldo BJ; Ye H; Sowalsky AG Oncogene; 2020 Aug; 39(34):5663-5674. PubMed ID: 32681068 [TBL] [Abstract][Full Text] [Related]
7. Control of mouse limb initiation and antero-posterior patterning by Meis transcription factors. Delgado I; Giovinazzo G; Temiño S; Gauthier Y; Balsalobre A; Drouin J; Torres M Nat Commun; 2021 May; 12(1):3086. PubMed ID: 34035267 [TBL] [Abstract][Full Text] [Related]
8. Somatic HOXB13 Expression Correlates with Metastatic Progression in Men with Localized Prostate Cancer Following Radical Prostatectomy. Weiner AB; Faisal FA; Davicioni E; Karnes RJ; Griend DJV; Lotan TL; Schaeffer EM Eur Urol Oncol; 2021 Dec; 4(6):955-962. PubMed ID: 32540218 [TBL] [Abstract][Full Text] [Related]
9. MEIS inhibitors reduce the viability of primary leukemia cells and Stem cells by inducing apoptosis. Meriç N; Albayrak E; Gülbaş Z; Kocabaş F Leuk Lymphoma; 2024 Feb; 65(2):187-198. PubMed ID: 37902585 [TBL] [Abstract][Full Text] [Related]
10. Epigenetic silencing of MEIS2 in prostate cancer recurrence. Nørgaard M; Haldrup C; Bjerre MT; Høyer S; Ulhøi B; Borre M; Sørensen KD Clin Epigenetics; 2019 Oct; 11(1):147. PubMed ID: 31640805 [TBL] [Abstract][Full Text] [Related]
12. The role of the MEIS homeobox genes in neuroblastoma. Geerts D; Schilderink N; Jorritsma G; Versteeg R Cancer Lett; 2003 Jul; 197(1-2):87-92. PubMed ID: 12880965 [TBL] [Abstract][Full Text] [Related]
13. Persistent transactivation by meis1 replaces hox function in myeloid leukemogenesis models: evidence for co-occupancy of meis1-pbx and hox-pbx complexes on promoters of leukemia-associated genes. Wang GG; Pasillas MP; Kamps MP Mol Cell Biol; 2006 May; 26(10):3902-16. PubMed ID: 16648484 [TBL] [Abstract][Full Text] [Related]
14. MEIS C termini harbor transcriptional activation domains that respond to cell signaling. Huang H; Rastegar M; Bodner C; Goh SL; Rambaldi I; Featherstone M J Biol Chem; 2005 Mar; 280(11):10119-27. PubMed ID: 15654074 [TBL] [Abstract][Full Text] [Related]
15. Transcription Factor ELF1 Modulates Cisplatin Sensitivity in Prostate Cancer by Targeting MEIS Homeobox 2. Han D; Li X; Cheng Y Chem Res Toxicol; 2023 Mar; 36(3):360-368. PubMed ID: 36763086 [TBL] [Abstract][Full Text] [Related]
16. MEIS and PBX homeobox proteins in ovarian cancer. Crijns AP; de Graeff P; Geerts D; Ten Hoor KA; Hollema H; van der Sluis T; Hofstra RM; de Bock GH; de Jong S; van der Zee AG; de Vries EG Eur J Cancer; 2007 Nov; 43(17):2495-505. PubMed ID: 17949970 [TBL] [Abstract][Full Text] [Related]
17. MEIS1 functions as a potential AR negative regulator. Cui L; Li M; Feng F; Yang Y; Hang X; Cui J; Gao J Exp Cell Res; 2014 Oct; 328(1):58-68. PubMed ID: 25158280 [TBL] [Abstract][Full Text] [Related]
18. Hypermethylated and downregulated MEIS2 are involved in stemness properties and oxaliplatin-based chemotherapy resistance of colorectal cancer. Wang X; Ghareeb WM; Zhang Y; Yu Q; Lu X; Huang Y; Huang S; Sun Y; Chi P J Cell Physiol; 2019 Aug; 234(10):18180-18191. PubMed ID: 30859572 [TBL] [Abstract][Full Text] [Related]
19. The Gene Regulatory Network of Lens Induction Is Wired through Meis-Dependent Shadow Enhancers of Pax6. Antosova B; Smolikova J; Klimova L; Lachova J; Bendova M; Kozmikova I; Machon O; Kozmik Z PLoS Genet; 2016 Dec; 12(12):e1006441. PubMed ID: 27918583 [TBL] [Abstract][Full Text] [Related]
20. Correlation Between Meis1 and Msi1 in Esophageal Squamous Cell Carcinoma. Moghbeli M; Rad A; Farshchian M; Taghehchian N; Gholamin M; Abbaszadegan MR J Gastrointest Cancer; 2016 Sep; 47(3):273-7. PubMed ID: 27142513 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]